We are live on
!
Find out more
HCM
Horton Capital Management Portfolio holdings
AUM
$44.9M
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+36.26%
1 Year Est. Return
-24.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$73.6M
AUM Growth
+$15.2M
(+26%)
Cap. Flow
+$175K
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UroGen Pharma
URGN
|
+$159K |
| 2 |
KORU Medical Systems
KRMD
|
+$15.9K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.66% |
| 2 | Technology | 12.09% |
| 3 | Financials | 5.08% |
| 4 | Industrials | 1.96% |
Similar funds
NCP
CO
IP
HR
WLRC
HCIL
AC
BBCM
Horton Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Horton Capital Management held 6 positions worth $73.6M, up 26% from $58.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 0%. Horton Capital Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 85% a quarter earlier, followed by Technology and Financials.
- Horton Capital Management added most to UroGen Pharma in Q2 2021, an estimated $159K increase.
- Horton Capital Management's ten largest holdings make up 100% of its $73.6M portfolio in Q2 2021.
- Horton Capital Management opened 0 new positions and closed 0 in Q2 2021.
- Horton Capital Management's portfolio value rose 26% quarter-over-quarter to $73.6M.
Based on Horton Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.